Kintor Pharmaceuticals Officially Listed New Third Board
Suzhou Kintor Pharmaceuticals Inc. , established in 2009, "B Village", is a high-tech enterprises which commits to the research and development ofinnovative drug. It's creation was led by Dr. Tong Youzhi and Dr. Guo Chuangxin, two distinguished experts on the list of our country's "Recruitment Program of Global Experts". This company has a modern experimental platform and high-quality pre-clinical and clinical R & D team, so they can simultaneously promote the developm
ent of several new drug projects.
Suzhou Kintor Pharmaceuticalsis intend to develop innovative drugs which with international advanced level in China for the treatment of critical diseases and Chinese patients can afford it. Since the establishment of the company, they have been focused on the construction of innovative drugs' R&D chain.Their main R&D project is the 1.1 classnew drug named Pukulamine which canresist prostate cancer and breast cancer. It is currently undergoing clinical trials in both the United States and China. The project was awarded the support of the special project "Major New Drug Creation" of the 12th Five-Year Plan, Science and Technology Support Plan of Jiangsu Province(social development) and Suzhou Science and Technology Program. It was awarded "the Second Prize of Medicine Science and Technology Progress Award " in the third Medical Science and Technology Award of Jiangsu Province in 2016. Kintor Pharmaceuticals has also been evaluated as " China's Top 50 Most Investment Value Companies ".
The listing of "The New Third Board" marks the birth of a historic milestone for Kintor Pharmaceuticals in its forward course.In the past years of development, Kintor Pharmaceuticals has won the investment form Oriza Holdings, Legend Star, Bioventure and HighLing Capatal. There are four companies in the "B Village" when the new third board are listed and it also has two listed companies in Nasdaq. So we can say that there are so many companies on the both sides of the ocean and they all are "Money Drawing" companies!
About Kintor Pharmaceuticals
Suzhou Kintor Pharmaceuticals Inc., established in 2009, is a high-tech enterprises which is commit to the research and development ofinnovative drug. This company has high-quality R & D team and experimental platform, and their research chain include a new generation of androgen receptor inhibition drugs, PI3K / mTOR targeted kinase inhibitiondrugs, CETP inhibitors which can prevent cardiovascular disease , JAK2 targeted Kinase Inhibitors for arthritis and FGFR / EGFR dual targeted kinase inhibition drugs for the treatment of various solid tumors such as liver cancer, ovarian cancer and lung cancer.
Since the establishment of the company, Suzhou Kintor Pharmaceuticalshas won the support of the special project "Major New Drug Creation" of the 12th Five-Year Plan, Innovation Fund for Small and Medium Enterprises of the Ministry of Science and Technology , Science and Technology Support Plan of Jiangsu Province(social development) and Suzhou Science and Technology Program and the Leading Personnel of Gusu Innovation and Entrepreneurship . It's successfully listedon the new third board in September 2016.The abbreviation of the securities: Kintor Pharmaceuticals; securities code: 839419. Suzhou Kintor Pharmaceuticals always holding the idea and philosophy of researching and developing Chinese local innovation drugs in the true meaning;continuing to study and explore and hoping to bring the gospel to patients so as to reduce the drug costs for majority of patients.